TinyGemsBreaks Archive - Page 2 of 147

FridayMay 29, 2026 10:47 am

TinyGemsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Expands DefendAir Production Capacity to Support Growing Counter-Drone Demand

ParaZero Technologies (NASDAQ: PRZO) an aerospace defense company focused on autonomous solutions for manned and unmanned aerial systems, announced it has engaged a subcontractor to support full-scale production of its DefendAir net pod systems. The new production line is expected to provide capacity for thousands of units annually and will include manufacturing, assembly and delivery processes designed to improve efficiency and support growing demand for the company's counter-UAS solutions. ParaZero said the expanded production capability will enhance its ability to deliver DefendAir systems across multiple configurations, including man-operated and autonomous applications, while strengthening its position in the rapidly growing drone defense market. To view the full press release, visit https://ibn.fm/ZMtNQ About ParaZero Technologies ParaZero Technologies Ltd. (NASDAQ:…

FridayMay 29, 2026 9:20 am

TinyGemsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Real-World Data Highlighting Widespread Opioid Use Among Fibromyalgia Patients

Tonix Pharmaceuticals (NASDAQ: TNXP) presented data at the 2026 American Society of Clinical Psychopharmacology Annual Meeting showing that opioid use remains common among U.S. adults diagnosed with fibromyalgia despite longstanding treatment guidelines discouraging their use. Based on a retrospective analysis of more than 261,000 patients in the Symphony Health claims database, the study found that approximately 40% of commercially insured, Medicare Advantage and Medicaid patients with fibromyalgia were prescribed at least one opioid, with tramadol and oxycodone representing the most common prescriptions. Tonix said the findings underscore a gap between clinical practice and evidence-based recommendations and highlight the need for…

WednesdayMay 27, 2026 2:30 pm

TinyGemsBreaks – Frontieras North America Inc. Is Unlocking Coal for Modern Industrial Demand

Frontieras is advancing its proprietary FASForm(TM) platform, which converts coal into fuels, hydrogen and industrial materials, positioning the resource as a multi-output industrial feedstock capable of supporting modern energy and manufacturing markets. A recent article quotes Matthew McKean, Frontieras cofounder and CEO, discussing the company’s Solid Carbon Fractionation technology. FASForm is “a patented, zero-waste process that takes coal and disassembles it at the molecular level into multiple higher-value products: ultra-low sulfur diesel, naphtha, purified solid carbon fuel, hydrogen, ammonium sulfate fertilizer, and industrial chemicals.” “No combustion. No emissions from the process itself,” McKean continues. “Six product streams from a single feedstock,…

ThursdayMay 21, 2026 9:30 am

TinyGemsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Conducts First U.S. Live DefendAir Counter-Drone Demonstration

ParaZero Technologies (NASDAQ: PRZO) announced the successful completion of its first live U.S. demonstration of its DefendAir counter-UAS net launcher system following SOF Week 2026 in Tampa, showcasing the platform to defense and security stakeholders including Tier-1 defense integrators, special forces, law enforcement representatives and distributors. During the demonstration, the DefendAir system achieved a 100% success rate intercepting multiple fast incoming FPV drone threats, supporting discussions around potential procurement, integration and deployment opportunities in U.S. and international defense markets. To view the full press release, visit https://ibn.fm/02rcN About ParaZero Technologies ParaZero Technologies Ltd. (Nasdaq: PRZO) is an aerospace defense company pioneering smart,…

WednesdayMay 20, 2026 9:20 am

TinyGemsBreaks – Rail Vision Ltd. (NASDAQ: RVSN, FSE: C80) Subsidiary Achieves Quantum Error Correction Integration Milestone Using Google Quantum AI Dataset

Rail Vision (NASDAQ: RVSN, FSE: C80) announced that its majority-owned subsidiary, Quantum Transportation Ltd., has successfully delivered a working integration layer that incorporates a publicly accessible experimental surface-code dataset from Google Quantum AI into its patent-pending quantum error correction transformer pipeline. The milestone advances Quantum Transportation’s transformer-based quantum decoder technology beyond internal data environments, reducing technical risk while establishing a scalable foundation for training and benchmarking neural quantum error correction systems using external experimental datasets. To view the full press release, visit https://ibn.fm/yIoih About Rail Vision Ltd. Rail Vision (Nasdaq: RVSN) is an early commercialization stage technology company transforming railway safety through…

FridayMay 15, 2026 3:45 pm

TinyGemsBreaks – Frontieras North America Inc. Developing FASForm(TM) to Unlock High-Value Fuels and Products from Coal

Frontieras is positioned as global energy systems are under increasing strain as industrial demand accelerates and reliable baseload power becomes more critical to economic stability. The company “is developing a breakthrough energy-processing technology known as FASForm(TM) that deconstructs coal and other solid hydrocarbons into multiple high-value fuels and industrial products, redefining the utility and economics of coal without burning it,” reads a recent article. “By unlocking the hidden components of coal through a patented Solid Carbon Fractionation process, the company is focused on delivering abundant, affordable, available energy solutions, and a new generation of diverse industrial revenue streams, from a resource…

ThursdayMay 14, 2026 10:30 am

TinyGemsBreaks – NextPlat Corp (NASDAQ: NXPL, NXPLW) Reports Improved First-Quarter 2026 Results Amid Turnaround Efforts

NextPlat (NASDAQ: NXPL, NXPLW) reported improved first-quarter 2026 operating results as ongoing turnaround initiatives drove stronger margins and reduced losses despite lower year-over-year revenue. The company posted quarterly revenue of $9.9 million, a record gross margin of 35%, and a 42% reduction in net loss attributable to common stockholders to approximately $1.1 million, ending the quarter with $11 million in cash and no unsecured debt as management targets positive operating income in the second half of 2026. To view the full press release, visit: https://ibn.fm/2rTDT About NextPlat Corp. NextPlat is a global consumer products and services company providing healthcare and…

ThursdayMay 14, 2026 10:20 am

TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) to Effect 1-for-27 Reverse Stock Split May 18

Aditxt (NASDAQ: ADTX), a social innovation platform accelerating health innovations, announced it will implement a 1-for-27 reverse stock split of its common stock, effective at the opening of trading on the Nasdaq Capital Market on May 18, 2026. The reverse split is intended to bring the company into compliance with Nasdaq’s minimum bid price requirement, reducing outstanding common shares from approximately 13.8 million to about 510,123, with the stock continuing to trade under the symbol ADTX. To view the full press release, visit https://ibn.fm/S1uMK About Aditxt, Inc. Aditxt, Inc. is a social innovation platform accelerating promising health innovations. Aditxt’s ecosystem…

ThursdayMay 14, 2026 9:50 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports First-Quarter 2026 Results, Advances Strategic Transformation

CNS Pharmaceuticals (NASDAQ: CNSP) reported first-quarter 2026 financial results while outlining progress in its strategic transformation toward an acquisition-driven growth model focused on clinical-stage neurology and oncology assets. Following quarter end, the company strengthened its balance sheet with a $22.5 million private placement, which, together with existing cash, is expected to support operations beyond 12 months as CNS pursues asset acquisitions and explores out-licensing opportunities for its legacy glioblastoma programs. To view the full press release, visit https://ibn.fm/HP5Xy About CNS Pharmaceuticals, Inc. CNS Pharmaceuticals is a biotechnology company focused on developing innovative therapies for serious diseases. With an experienced executive…

MondayMay 11, 2026 9:30 am

TinyGemsBreaks – Kairos Pharma Ltd. (NYSE American: KAPA) Sets Virtual Annual Meeting, Discloses Going Concern Notice

Kairos Pharma (NYSE American: KAPA) announced that its annual meeting of shareholders will be held virtually at 9 a.m. PDT on June 29, 2026, with meeting materials to be mailed following finalization and filing with the SEC. The clinical-stage biopharmaceutical company also disclosed that its 2025 annual report included an audit report containing a going concern explanatory paragraph from its independent registered public accounting firm, as required under Section 610(b) of the NYSE American Company Guide, noting the disclosure does not reflect any change or amendment to previously filed financial statements. To view the full press release, visit https://ibn.fm/sQ0pm About…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks